APA (7th ed.) Citation

Zhang, W., Zhang, X., Zhao, W., Guo, Z., Liu, X., Ye, L., . . . He, Y. (2024). What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation. BMC Pulmonary Medicine, 24(1), 1. https://doi.org/10.1186/s12890-024-03438-3

Chicago Style (17th ed.) Citation

Zhang, Wengang, et al. "What Is the Optimal First-line Regimen for Advanced Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation." BMC Pulmonary Medicine 24, no. 1 (2024): 1. https://doi.org/10.1186/s12890-024-03438-3.

MLA (9th ed.) Citation

Zhang, Wengang, et al. "What Is the Optimal First-line Regimen for Advanced Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation." BMC Pulmonary Medicine, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12890-024-03438-3.